Basic science of osteoarthritis

被引：72

作者：

Cucchiarini M. ^{[1
]}

de Girolamo L. ^{[2
]}

Filardo G. ^{[3
]}

Oliveira J.M. ^{[4
,5
]}

Orth P. ^{[1
,6
]}

Pape D. ^{[7
,8
]}

Reboul P. ^{[9
]}

机构：

[1] Center of Experimental Orthopaedics, Saarland University Medical Center and Saarland University, Kirrbergerstr. Bldg 37, Homburg

[2] Orthopaedic Biotechnology Laboratory, Galeazzi Orthopaedic Institute, Milan

[3] Orthopaedic and Traumatologic I Clinic, Biomechanics Laboratory, Rizzoli Orthopaedic Institute, University of Bologna, Bologna

[4] 3B’s Research Group - Biomaterials, Biodegradables and Biomimetics, Univ. Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark - Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barc

[5] ICVS/3B’s - PT Government Associated Laboratory, Barco, Guimarães

[6] Department of Orthopaedic Surgery, Saarland University Medical Center and Saarland University, Homburg, Saar

[7] Department of Orthopaedic Surgery, Centre Hospitalier de Luxembourg, Luxembourg ville

[8] Sports Medicine Research Laboratory, Public Research Centre for Health, Luxembourg, Centre Médical de la Fondation Norbert Metz, Luxembourg ville

[9] UMR 7365 CNRS-Université de Lorraine, IMoPA, Biopôle de l’Université de Lorraine, Campus Biologie-Santé, Vandoeuvre-lès-Nancy

来源：

Journal of Experimental Orthopaedics | / 3卷 / 1期

关键词：

Animal models; Articular cartilage; Bone; Interface; Osteoarthritis; Pathomechanisms; Stem cells; Tissue engineering;

D O I：

10.1186/s40634-016-0060-6

中图分类号：

学科分类号：

摘要：

Osteoarthritis (OA) is a prevalent, disabling disorder of the joints that affects a large population worldwide and for which there is no definitive cure. This review provides critical insights into the basic knowledge on OA that may lead to innovative end efficient new therapeutic regimens. While degradation of the articular cartilage is the hallmark of OA, with altered interactions between chondrocytes and compounds of the extracellular matrix, the subchondral bone has been also described as a key component of the disease, involving specific pathomechanisms controlling its initiation and progression. The identification of such events (and thus of possible targets for therapy) has been made possible by the availability of a number of animal models that aim at reproducing the human pathology, in particular large models of high tibial osteotomy (HTO). From a therapeutic point of view, mesenchymal stem cells (MSCs) represent a promising option for the treatment of OA and may be used concomitantly with functional substitutes integrating scaffolds and drugs/growth factors in tissue engineering setups. Altogether, these advances in the fundamental and experimental knowledge on OA may allow for the generation of improved, adapted therapeutic regimens to treat human OA. © 2016, The Author(s).

引用

共 131 条

[71]

Loeser R.F., Integrins and chondrocyte-matrix interactions in articular cartilage, Matrix Biol, 39, pp. 11-16, (2014)

[72]

Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B., Osteoarthritis: a disease of the joint as an organ, Arthritis Rheum, 64, 6, pp. 1697-1707, (2012)

[73]

Luyten F.P., Denti M., Filardo G., Kon E., Engebretsen L., Definition and classification of early osteoarthritis of the knee, Knee Surg Sports Traumatol Arthrosc, 20, 3, pp. 401-406, (2012)

[74]

Madry H., Kon E., Condello V., Peretti G.M., Steinwachs M., Seil R., Berruto M., Engebretsen L., Filardo G., Angele P., Early osteoarthritis of the knee, Knee Surg Sports Traumatol Arthrosc, 24, 6, pp. 1753-1762, (2016)

[75]

Malemud C.J., Martel-Pelletier J., Pelletier J.P., Degradation of extracellular matrix in osteoarthritis: 4 fundamental questions, J Rheumatol, 14, pp. 20-22, (1987)

[76]

Manferdini C., Maumus M., Gabusi E., Piacentini A., Filardo G., Peyrafitte J.A., Jorgensen C., Bourin P., Fleury-Cappellesso S., Facchini A., Noel D., Lisignoli G., Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2, Arthritis Rheum, 65, 5, pp. 1271-1281, (2013)

[77]

Mansell J.P., Bailey A.J., Abnormal cancellous bone collagen metabolism in osteoarthritis, J Clin Invest, 101, 8, pp. 1596-1603, (1998)

[78]

Martin-Millan M., Castaneda S., Estrogens, osteoarthritis and inflammation, Joint Bone Spine, 80, 4, pp. 368-373, (2013)

[79]

Massicotte F., Lajeunesse D., Benderdour M., Pelletier J.P., Hilal G., Duval N., Martel-Pelletier J., Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients, Osteoarthritis Cartilage, 10, 6, pp. 491-500, (2002)

[80]

Massicotte F., Aubry I., Martel-Pelletier J., Pelletier J.P., Fernandes J., Lajeunesse D., Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts, Arthritis Res Ther, 8, 6, pp. R177-R188, (2006)

← 3 4 5 6 7 8 9 10 11 12 →